Millions of Americans rely on GLP-1 drugs to improve their health, but bad actors are peddling dangerous fakes.” ...
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Sky-high demand, a high price tag and tight supplies have created opportunities for bad actors to take advantage of consumers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback